Safety and Efficacy of Oshadi D and Oshadi R in Basal Cell Carcinoma Patients Prior to Tumor Excision a Phase 2 Study
PHASE2CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
November 30, 2013
Primary Completion Date
March 31, 2017
Study Completion Date
March 31, 2017
Conditions
BCC
Interventions
DRUG
Oshadi D & Oshadi R
Anti tumor agents
Trial Locations (1)
Unknown
Assaf-Harofeh Medical Center, Zrifin
All Listed Sponsors
lead
Oshadi Drug Administration
INDUSTRY
NCT02007317 - Safety and Efficacy of Oshadi D and Oshadi R in Basal Cell Carcinoma Patients Prior to Tumor Excision a Phase 2 Study | Biotech Hunter | Biotech Hunter